Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
archive
coronavirus
fda
medicine
astellas pharma
atlas venture
audentes therapeutics
avidity biosciences
biotech
bluebird bio
boston
boston blog main
boston top stories
clinical trials
covid-19
duchenne muscular dystrophy
dyne therapeutics
facioscapulohumeral muscular dystrophy
gene therapy
joshua brumm
kaleido biosciences
life sciences
medical
muscular dystrophy
myotonic dystrophy type 1
national blog main
national top stories
new york blog main
rare disease drugs
recalls
romesh subramanian
safety
san diego blog main
san francisco blog main
susanna high
usa
vertex pharmaceuticals
What
drug
4
×
expected
4
×
covid
acella
addition
administration
ago
aiming
announced
antibodies
antibody
aren’t
assuming
authorizations
authorized
authorizes
based
biotechs
booster
boosters
clinical
conduct
considering
coronavirus
country
crucial
data
diseases
dyne
early
estimates
experimental
eyes
fda
food
genetic
granted
having
humans
hypothyroidism
Language
unset
Current search:
expected
×
drug
×
@slashgear.com
2 years ago
FDA authorizes two more COVID-19 boosters with mix-and-match strategy
@slashgear.com
2 years ago
Popular thyroid drug recalled because the pills aren’t potent enough
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@bgr.com
4 years ago
Crucial coronavirus antibody drug could be ready sooner than expected
